Please enable JavaScript.

Coggle requires JavaScript to display documents.

DR REDDY'S LABS Value Generated: Financial Resilience Sustainable…

- - - - Revenue from India: ₹48.9 billion (17% growth)
        
        Emerging Markets revenue: ₹45.5 billion
        
        Gross Profit Margin: 56.7%
  - - - 165 Metric Tonannual reduction in carbon emissions
- - - - Mayne reported $111 million (USD) in earned revenue for 2023
      - 45 commercial products
      - 4 pipeline products
      - 40 approved non-marketed products
      - Products for women's healthcare
  - - - Expected EPS Impact: 4% dilution (FY2025E)
- - - - Impact on Profits: ₹4,081 - ₹5,950 (Share Price)
  - - - Uncommitted lines of credit: Rs 50,194 million
- - - - Diversification and Investment
        
        Revenue Growth: 14.50%
        Operating Profit Margin (OPM): 26%
        ROCE: 26.33%
        RONA 29.59%
      - Operational Efficiency
      - Market Position
      - Industry Recognition
- - - - Shareholder's Equity Growth: Rs 23,286 million
- - - - 26% Operating Profit Margin (OPM) in 2023
        Compound Annual Growth Rate (CAGR) from 2019 to 2023 is 14.78%
        Societal well-being is further reinforced by a consistent Dividend Payout Percentage, averaging at 19.8% from 2019 to 2023